These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1794742)

  • 1. Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications.
    Ferrari A; Pasqualetti D; Del Bianco P; Gandolfo GM; Chistolini A; Mazzucconi MG
    Haematologica; 1991; 76(4):342-5. PubMed ID: 1794742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy.
    Pogliani EM; Della Volpe A; Casaroli I; Maffe PF; Corneo G
    Allergol Immunopathol (Madr); 1991; 19(3):113-6. PubMed ID: 1799168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of lymphocyte subpopulations in chronic autoimmune inflammatory rheumatic diseases. II. Polymyalgia rheumatica: behaviour of lymphocyte subpopulations during treatment with two different corticosteroids].
    Coaccioli S; Pinoca F; Giuliani M; Sabatini C; Puxeddu A
    Minerva Med; 2005 Oct; 96(5):379-87. PubMed ID: 16227953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deflazacort in the treatment of uveitis: a comparative study versus prednisone.
    Cerqueti Piera M; Saccà Sergio C; Allegri P; Ciurlo G; Zingirian M; Buscaglia S; Ciprandi G
    Allergol Immunopathol (Madr); 1993; 21(3):107-10. PubMed ID: 8356936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
    Rebollo Bernárdez J; Cifuentes Mimoso C; Piñar Moreno A; Caunedo Alvarez A; Salas Herrero E; Jiménez-Sáenz M; Herrerías Gutiérrez J
    Rev Esp Enferm Dig; 1999 Sep; 91(9):630-8. PubMed ID: 10502711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study comparing deflazacort and prednisone in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
    J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deflazacort in thrombocytopenia: a comparison with prednisone.
    Mazzucconi MG; Malagnino F; De Laurentis C; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):538-42. PubMed ID: 7194867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
    Sikorska A; Konopka L; Maślanka K
    Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].
    Masłowska E; Wysocki M; Michalak-Nowaczyk A
    Pediatr Pol; 1996 Jan; 71(1):25-9. PubMed ID: 8966063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
    Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
    Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
    Dubbeld P; van der Heul C; Hillen HF
    Neth J Med; 1991 Aug; 39(1-2):6-10. PubMed ID: 1961352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies.
    Scandellari R; Allemand E; Vettore S; Plebani M; Randi ML; Fabris F
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):108-13. PubMed ID: 19786938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
    Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
    Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary experience with deflazacort, a new synthetic steroid with fewer undesirable side effects, in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; Montero A; Sancho M; López-Rubio F; Latre JM; Calleja F; Casares J; Román M
    J Heart Lung Transplant; 1993; 12(3):445-8; discussion 448-9. PubMed ID: 8329416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.